The project integrating genetic and clinical data to predict cancer risk, in which members of the UCC participate, has been selected for the second phase of the research call.
In the fourth edition of the “La Caixa” Foundation’s call for projects in biomedicine and health (HR2021), 644 projects were presented in the following thematic areas:
- Cardiovascular and related metabolic diseases
- Infectious diseases
- Enabling technologies in the above four thematic areas.
The selection of proposals is based on a rigorous peer review process. It consists of a first phase of remote pre-selection and a second phase of face-to-face selection by committees of experts in each of the research areas.
A total of 158 projects from the Oncology area have been submitted. The projects with the best scores go on to a second phase (<10%) consisting of an interview with a committee of 8-12 experts. The project integrating genetic and clinical data to predict cancer risk, in which the UCC participates, has been selected for the second phase.
The project aims to develop an artificial intelligence tool that integrates clinical and genetic data to assess the risk of developing different types of cancer.